Search Results 121-130 of 15579 for B%20cell%20lymphomas
Learn about this type of non-Hodgkin's lymphoma that attacks the skin. Find out about cutaneous T-cell lymphoma (CTCL) symptoms, diagnosis and treatments.
— Feb. 18, 2014 — Newly-diagnosed patients with diffuse large B cell lymphoma (DLBCL) who do not experience any cancer-related outcome events for two years ...
... B-cell non-Hodgkin's lymphoma that has returned or is resistant to treatment. Participation eligibility. Participant eligibility includes age, gender, type ...
Clinical Trials · Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma · More about research at Mayo ...
The purpose of this study is to determine the maximum tolerated dose of this drug (MEDI-551) in subjects with advanced B-cell malignancies. Expansion to occur ...
The purpose of this study is to assess the safety, tolerability and pharmacokinetics (PK) of CYT-0851 in patients with relapsed/refractory B-cell malignancies ...
The purpose of tis study is to evaluate whether adding brentuximab vedotin helps two drugs work better to treat patients with diffuse large B-cell lymphoma ( ...
... B-Cell Lymphoma (DLBCL) Participants. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More ...
It targets the B-cell lymphoma 2 (BCL-2) protein, which supports cancer cell growth and is overexpressed in many patients with mantle cell lymphoma. Venetoclax ...
The laboratory of Diane F. Jelinek, Ph.D., studies normal human B cell (lymphocyte) and plasma cell biology as well as several human B cell cancers. Dr.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make your tax-deductible gift and be a part of the cutting-edge research and care that's changing medicine.